Skip to content
RushPR News – Lifestyle
Author:
Trogenix
Trogenix appoints industry veterans John Young as Chair and Josh Murray as Non-Executive Director to support global strategy, commercial foundation and patient access
November 10, 2026
Trogenix doses first patient in Phase I/II clinical trial of TGX-007 gene therapy for glioblastoma
May 28, 2026